Mingzi Ouyang

512 total citations
15 papers, 429 citations indexed

About

Mingzi Ouyang is a scholar working on Molecular Biology, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mingzi Ouyang has authored 15 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Pharmacology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mingzi Ouyang's work include Pharmacological Effects of Natural Compounds (3 papers), Chemotherapy-induced organ toxicity mitigation (2 papers) and Cancer Treatment and Pharmacology (2 papers). Mingzi Ouyang is often cited by papers focused on Pharmacological Effects of Natural Compounds (3 papers), Chemotherapy-induced organ toxicity mitigation (2 papers) and Cancer Treatment and Pharmacology (2 papers). Mingzi Ouyang collaborates with scholars based in China. Mingzi Ouyang's co-authors include Yingchao Wu, Yanyan Liu, Wei Tan, Yiliu Chen, Qian Zuo, Xiaoshan Zhao, Ren Luo, Ya Xiao, Yanyan Liu and Huan Ye and has published in prestigious journals such as International Journal of Biological Macromolecules, Frontiers in Pharmacology and Evidence-based Complementary and Alternative Medicine.

In The Last Decade

Mingzi Ouyang

15 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mingzi Ouyang China	9	195	91	75	69	63	15	429
Jiangyan Xu China	14	258 1.3×	100 1.1×	65 0.9×	45 0.7×	93 1.5×	30	506
Shanshan Su China	13	208 1.1×	97 1.1×	54 0.7×	55 0.8×	30 0.5×	39	493
Yidi Qu China	13	277 1.4×	25 0.3×	66 0.9×	85 1.2×	72 1.1×	19	558
Ehsan Jangholi Iran	11	168 0.9×	45 0.5×	33 0.4×	21 0.3×	40 0.6×	32	432
Yunu Jung South Korea	16	253 1.3×	27 0.3×	55 0.7×	66 1.0×	29 0.5×	23	602
Yilixiati Xiaokaiti China	13	227 1.2×	36 0.4×	23 0.3×	32 0.5×	43 0.7×	16	451
Larissa Akemi Kido Brazil	14	195 1.0×	107 1.2×	21 0.3×	18 0.3×	52 0.8×	37	466
Xi‐Ding Yang China	11	360 1.8×	67 0.7×	29 0.4×	128 1.9×	88 1.4×	18	588
Qingjun Cao China	9	156 0.8×	64 0.7×	73 1.0×	100 1.4×	49 0.8×	14	430
Dong‐Hyun Youn South Korea	15	246 1.3×	20 0.2×	51 0.7×	78 1.1×	25 0.4×	24	567

Countries citing papers authored by Mingzi Ouyang

Since Specialization

Citations

This map shows the geographic impact of Mingzi Ouyang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingzi Ouyang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingzi Ouyang more than expected).

Fields of papers citing papers by Mingzi Ouyang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingzi Ouyang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingzi Ouyang. The network helps show where Mingzi Ouyang may publish in the future.

Co-authorship network of co-authors of Mingzi Ouyang

This figure shows the co-authorship network connecting the top 25 collaborators of Mingzi Ouyang. A scholar is included among the top collaborators of Mingzi Ouyang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingzi Ouyang. Mingzi Ouyang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Wu, Yingchao, et al.. (2025). Saikosaponin A induces cellular senescence in triple-negative breast cancer by inhibiting the PI3K/Akt signalling pathway. Frontiers in Pharmacology. 16. 1532579–1532579. 2 indexed citations

Chen, Yiliu, Jiaqi Cui, Zhiyu Chen, et al.. (2025). Atractylodes lancea (Thunb.) DC polysaccharide structural properties and its protective impact on cisplatin-induced gastrointestinal harm by restoring the intestinal barrier and gut flora. International Journal of Biological Macromolecules. 318(Pt 4). 145232–145232. 1 indexed citations

Wu, Yingchao, Hui Wang, Liang Zheng, et al.. (2024). Elucidating the mechanism of traditional Chinese medicine formula (Yifei-sanjie Pill) in alleviating the chemobrain based on network pharmacology and experimental verification. Journal of Traditional and Complementary Medicine. 16(1). 17–30. 1 indexed citations

Wu, Yingchao, Yangyang Dong, Wuhong Wang, et al.. (2023). Deciphering the Molecular Mechanism of Yifei-Sanjie Pill in Cancer-Related Fatigue. Journal of Oncology. 2023. 1–19. 8 indexed citations

Wu, Yingchao, et al.. (2023). Yiqi Chutan Formula Reverses Cisplatin-Induced Apoptosis and Ferroptosis of Skeletal Muscle by Alleviating Oxidative Stress. Integrative Cancer Therapies. 22. 1563487253–1563487253. 8 indexed citations

Wu, Yingchao, Shuyao Zhou, Yangyang Dong, et al.. (2023). Ginsenoside Rh3 induces pyroptosis and ferroptosis through the Stat3/p53/NRF2 axis in colorectal cancer cells. Acta Biochimica et Biophysica Sinica. 55(4). 587–600. 60 indexed citations

Chen, Yiliu, et al.. (2022). Luteolin induces pyroptosis in HT-29 cells by activating the Caspase1/Gasdermin D signalling pathway. Frontiers in Pharmacology. 13. 952587–952587. 30 indexed citations

Wu, Yingchao, et al.. (2022). Ginsenoside Rh4 Inhibits Colorectal Cancer Cell Proliferation by Inducing Ferroptosis via Autophagy Activation. Evidence-based Complementary and Alternative Medicine. 2022. 1–19. 40 indexed citations

Wu, Yingchao, et al.. (2022). Yifei sanjie Pills Alleviate Chemotherapy-Related Fatigue by Reducing Skeletal Muscle Injury and Inhibiting Tumor Growth in Lung Cancer Mice. Evidence-based Complementary and Alternative Medicine. 2022. 1–19. 12 indexed citations

10.

Ouyang, Mingzi, et al.. (2021). Kai-Xin-San Attenuates Doxorubicin-Induced Cognitive Impairment by Reducing Inflammation, Oxidative Stress, and Neural Degeneration in 4T1 Breast Cancer Mice. Evidence-based Complementary and Alternative Medicine. 2021. 1–15. 22 indexed citations

11.

Lin, Lizhu, et al.. (2019). Zhengyuan capsule alleviates chemotherapy-related fatigue in nude mice with human lung adenocarcinoma A549 xenografts. 6(1). 3–11. 1 indexed citations

12.

Ouyang, Mingzi, Qian Zuo, Zhuo Lv, et al.. (2016). Effects of the polysaccharides extracted from Ganoderma lucidum on chemotherapy-related fatigue in mice. International Journal of Biological Macromolecules. 91. 905–910. 23 indexed citations

13.

Ouyang, Mingzi, Yanyan Liu, Wei Tan, et al.. (2014). Bu-Zhong-Yi-Qi pill alleviate the chemotherapy-related fatigue in 4 T1 murine breast cancer model. BMC Complementary and Alternative Medicine. 14(1). 497–497. 22 indexed citations

14.

Xiao, Ya, et al.. (2012). Chinese Herbal Medicine Liu Jun Zi Tang and Xiang Sha Liu Jun Zi Tang for Functional Dyspepsia: Meta-Analysis of Randomized Controlled Trials. Evidence-based Complementary and Alternative Medicine. 2012. 1–7. 52 indexed citations

15.

Tan, Wei, et al.. (2011). Anti-fatigue activity of polysaccharides extract from Radix Rehmanniae Preparata. International Journal of Biological Macromolecules. 50(1). 59–62. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact